Investors should buy the Omicron-led dip in the stock market because the new variant might accelerate the end of the pandemic, JPMorgan says Matthew Fox 02 dec 2021
Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue Matthew Fox 01 dec 2021
A metaverse ETF has seen inflows surge 548% since Facebook’s name change. Here are its top 10 holdings. Matthew Fox 01 dec 2021
3 reasons why the stock market just bottomed and will rally into year-end, according to Fundstrat’s Tom Lee Matthew Fox 01 dec 2021
A crypto trader known as ‘Coin Signals’ pled guilty to swindling millions from investors by promising returns of nearly 150% Matthew Fox 30 nov 2021
Adagio Therapeutics extends 3-day gain to 319% on hopes that its antiviral can treat the Omicron variant Matthew Fox 30 nov 2021
Bitcoin’s successful test of support in weekend sell-off puts it back on track to rise 53% from current levels, Katie Stockton says Matthew Fox 30 nov 2021
Here are the 10 meme stocks held by an upcoming ETF that will invest in heavily shorted companies Matthew Fox 30 nov 2021
